Department of Chemistry, Indian Institute of Technology Guwahati, Assam, India.
Chem Commun (Camb). 2020 Nov 25;56(91):14137-14153. doi: 10.1039/d0cc05489e. Epub 2020 Oct 15.
The use of synthetic ion transporters for alteration of the concentration of ions across cell membranes has drawn attention from scientists over the last two decades. This ion transport property has been sensibly used to reduce the viability of cancer cells mainly due to the disruption of their ion homeostasis, leading to the perturbation of their abnormal pH gradient. The use of the proanionophore strategy has been recently adopted to increase cellular deliverability and reduce unwanted cytotoxicity towards normal cells. Meanwhile, various anionophores exhibiting non-toxic behavior in epithelial cells have shown a great propensity to be used as a putative treatment for channelopathies like cystic fibrosis. Anionophores with Cl ion transport mediated antibacterial activities have also been successfully used against clinically relevant bacterial strains, many of which are tolerant towards commercial antibiotics. Recent developments in the chloride ion transport mediated biological activities of anionophores have been mainly discussed in this article. It also highlights other aspects, such as design criteria, targeted delivery options, and others, which can be useful for the further development of selective anionophores for specific biological applications.
在过去的二十年中,科学家们一直关注使用合成离子转运蛋白来改变细胞膜两侧离子的浓度。这种离子转运特性已被合理用于降低癌细胞的活力,主要是因为其离子动态平衡被破坏,导致异常 pH 梯度受到干扰。最近,人们采用了前阴离子载体策略来提高细胞摄取率,并降低对正常细胞的不必要细胞毒性。同时,各种在上皮细胞中表现出无毒行为的阴离子载体已显示出作为囊性纤维化等通道病潜在治疗方法的巨大潜力。具有 Cl-离子转运介导的抗菌活性的阴离子载体也已成功用于对抗临床上相关的细菌菌株,其中许多对商业抗生素具有耐受性。本文主要讨论了阴离子载体介导的氯离子转运的生物学活性的最新进展。它还强调了其他方面,如设计标准、靶向递送选择等,这些对于进一步开发用于特定生物学应用的选择性阴离子载体可能是有用的。